Global Drug Discovery Informatics Market Size, Share, Trends, Industry Analysis Report: By Application, By Mode, By Services, By End-User, and By Region - Market Forecast, 2024

Description

List of Tables

The global drug discovery informatics market size is expected to reach USD 8,132.56 million by 2032, according to a new study by Polaris Market Research. The report "Global Drug Discovery Informatics Market Size, Share, Trends, Industry Analysis Report: Information By Application (Drug Discovery, Drug Development), By Mode, By Services, By End-User, and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Technological advancements such as integration with artificial intelligence and cloud computing are propelling the growth of the drug discovery informatics market. Several technology-based companies are introducing drug discovery solutions to meet the burgeoning needs of the healthcare industry. The application of AI in healthcare is revolutionizing the drug discovery process, making it more adept at handling the complexity of biomedical data. Therefore, innovative technological upgrades are propelling the growth of the drug discovery informatics market.

Moreover, the substantial investments made by companies to accelerate drug discovery processes are also fueling market growth. These investments have bolstered the capabilities of drug discovery informatics, paving the way for innovative therapeutics. Consequently, the combination of advanced informatics models with substantial financial backing is fostering drug development, thus stimulating the growth of the drug discovery informatics market.

The expansion and growth activities of industry players also fuel the development of drug discovery informatics. The activities include acquisitions, collaborations, and partnerships with research organizations, academic institutions, and pharmaceutical companies to drive innovation in the market. Moreover, the drug discovery informatics market is competitive, with several global and regional players vying for market dominance. Global players are dominating the market with innovative offerings that cover AI-driven insights, data analytics, and cloud-based solutions tailored specifically for pharmaceutical research.

Drug Discovery Informatics Market Report Highlights

The market's drug development segment is expected to experience substantial growth in the coming years due to the rising research and development activities by pharmaceutical companies.

In 2023, the sequence analysis platforms segment dominated the market in terms of revenue because advanced platforms such as BLAST, FASTA, and CLUSTALW significantly facilitated modern drug discovery and development. These platforms empowered researchers to analyze and interpret vast amounts of genomic data efficiently.

The North American drug discovery informatics market held the largest revenue share due to the presence of a robust pharmaceutical industry.

The growing interest of global drug discovery informatics companies in China as a key player in drug discovery and development is expected to drive the growth in the China drug discovery informatics market.

The global key market players are Accenture, Agilent Technologies, Inc., Boehringer Ingelheim International GmbH, Certara, Charles River Laboratories, Chemaxon Ltd., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Illumina, Inc., Infosys Limited, Jubilant Biosys Ltd., Oracle, QIAGEN, Sapio Sciences, and Selvita.

Polaris Market Research has segmented the drug discovery informatics market report based on application, mode, services, end-user, and region:

Drug Discovery Informatics, Application Outlook (Revenue - USD Million, 2019 - 2032)

Drug Discovery
Identification, Validation, & Assay Development Informatics
Lead Generation
Drug Development
FHD Preparation
Lead Optimization
Phase IA
Phase IB/2

Drug Discovery Informatics, Mode Outlook (Revenue - USD Million, 2019 - 2032)

Outsourced
In-house

Drug Discovery Informatics, Services Outlook (Revenue - USD Million, 2019 - 2032)

Clinical Trial Data Management
Docking
Molecular Modeling
Sequence Analysis Platforms
Others

Drug Discovery Informatics, End User Outlook (Revenue - USD Million, 2019 - 2032)

Biotechnology Companies
Contract Research Organization (CROs)
Pharmaceutical Companies
Others

Drug Discovery Informatics, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of APAC
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of MEA

Product Code: PM1870

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Drug Discovery Informatics Market Insights

4.1. Drug Discovery Informatics Market - Application Snapshot
4.2. Drug Discovery Informatics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Significant growth strategies employed by industry players are driving the drug discovery informatics market growth
  - 4.2.1.2. Government initiatives for developing products for rare diseases are propelling the drug discovery informatics market size
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Inconsistent data quality is hindering the adoption of drug discovery informatics
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Drug Discovery Informatics Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Drug Discovery Informatics Market, by Application

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
5.3. Drug Discovery
- 5.3.1. Global Drug Discovery Informatics Market, by Drug Discovery, by Region, 2019-2032 (USD Million)
- 5.3.2. Identification, Validation, & Assay Development Informatics
  - 5.3.2.1. Global Drug Discovery Informatics Market, by Identification, Validation, & Assay Development Informatics, by Region, 2019-2032 (USD Million)
- 5.3.3. Lead Generation
  - 5.3.3.1. Global Drug Discovery Informatics Market, by Lead Generation, by Region, 2019-2032 (USD Million)
5.4. Drug Development
- 5.4.1. Global Drug Discovery Informatics Market, by Drug Development, by Region, 2019-2032 (USD Million)
- 5.4.2. FHD Preparation
  - 5.4.2.1. Global Drug Discovery Informatics Market, by FHD Preparation, by Region, 2019-2032 (USD Million)
- 5.4.3. Lead Optimization
  - 5.4.3.1. Global Drug Discovery Informatics Market, by Lead Optimization, by Region, 2019-2032 (USD Million)
- 5.4.4. Phase IA
  - 5.4.4.1. Global Drug Discovery Informatics Market, by Phase IA, by Region, 2019-2032 (USD Million)
- 5.4.5. Phase IB/2
  - 5.4.5.1. Global Drug Discovery Informatics Market, by Phase IB/2, by Region, 2019-2032 (USD Million)

6. Global Drug Discovery Informatics Market, by Mode

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
6.3. Outsourced
- 6.3.1. Global Drug Discovery Informatics Market, by Outsourced, by Region, 2019-2032 (USD Million)
6.4. In-house
- 6.4.1. Global Drug Discovery Informatics Market, by In-house, by Region, 2019-2032 (USD Million)

7. Global Drug Discovery Informatics Market, by Services

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
7.3. Clinical Trial Data Management
- 7.3.1. Global Drug Discovery Informatics Market, by Clinical Trial Data Management, by Region, 2019-2032 (USD Million)
7.4. Docking
- 7.4.1. Global Drug Discovery Informatics Market, by Docking, by Region, 2019-2032 (USD Million)
7.5. Molecular Modeling
- 7.5.1. Global Drug Discovery Informatics Market, by Molecular Modeling, by Region, 2019-2032 (USD Million)
7.6. Sequence Analysis Platforms
- 7.6.1. Global Drug Discovery Informatics Market, by Sequence Analysis Platforms, by Region, 2019-2032 (USD Million)
7.7. Others
- 7.7.1. Global Drug Discovery Informatics Market, by Others, by Region, 2019-2032 (USD Million)

8. Global Drug Discovery Informatics Market, by End User

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
8.3. Biotechnology Companies
- 8.3.1. Global Drug Discovery Informatics Market, by Biotechnology Companies, by Region, 2019-2032 (USD Million)
8.4. Contract Research Organization (CROs)
- 8.4.1. Global Drug Discovery Informatics Market, by Contract Research Organization (CROs), by Region, 2019-2032 (USD Million)
8.5. Pharmaceutical Companies
- 8.5.1. Global Drug Discovery Informatics Market, by Pharmaceutical Companies, by Region, 2019-2032 (USD Million)
8.6. Others
- 8.6.1. Global Drug Discovery Informatics Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Drug Discovery Informatics Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Drug Discovery Informatics Market Assessment, By Geography, 2019-2032 (USD Million)
9.3. Drug Discovery Informatics Market - North America
- 9.3.1. North America: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
- 9.3.2. North America: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
- 9.3.3. North America: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
- 9.3.4. North America: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.3.5. Drug Discovery Informatics Market - U.S.
  - 9.3.5.1. U.S.: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.3.5.2. U.S.: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.3.5.3. U.S.: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.3.5.4. U.S.: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.3.6. Drug Discovery Informatics Market - Canada
  - 9.3.6.1. Canada: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.3.6.2. Canada: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.3.6.3. Canada: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.3.6.4. Canada: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
9.4. Drug Discovery Informatics Market - Europe
- 9.4.1. Europe: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
- 9.4.2. Europe: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
- 9.4.3. Europe: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
- 9.4.4. Europe: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.4.5. Drug Discovery Informatics Market - UK
  - 9.4.5.1. UK: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.4.5.2. UK: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.4.5.3. UK: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.4.5.4. UK: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.4.6. Drug Discovery Informatics Market - France
  - 9.4.6.1. France: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.4.6.2. France: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.4.6.3. France: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.4.6.4. France: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.4.7. Drug Discovery Informatics Market - Germany
  - 9.4.7.1. Germany: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.4.7.2. Germany: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.4.7.3. Germany: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.4.7.4. Germany: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.4.8. Drug Discovery Informatics Market - Italy
  - 9.4.8.1. Italy: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.4.8.2. Italy: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.4.8.3. Italy: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.4.8.4. Italy: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.4.9. Drug Discovery Informatics Market - Spain
  - 9.4.9.1. Spain: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.4.9.2. Spain: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.4.9.3. Spain: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.4.9.4. Spain: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.4.10. Drug Discovery Informatics Market - Netherlands
  - 9.4.10.1. Netherlands: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.4.10.2. Netherlands: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.4.10.3. Netherlands: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.4.10.4. Netherlands: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.4.11. Drug Discovery Informatics Market - Russia
  - 9.4.11.1. Russia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.4.11.2. Russia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.4.11.3. Russia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.4.11.4. Russia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.4.12. Drug Discovery Informatics Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.4.12.2. Rest of Europe: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.4.12.3. Rest of Europe: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.4.12.4. Rest of Europe: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
9.5. Drug Discovery Informatics Market - Asia Pacific
- 9.5.1. Asia Pacific: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
- 9.5.2. Asia Pacific: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
- 9.5.3. Asia Pacific: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
- 9.5.4. Asia Pacific: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.5.5. Drug Discovery Informatics Market - China
  - 9.5.5.1. China: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.5.5.2. China: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.5.5.3. China: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.5.5.4. China: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.5.6. Drug Discovery Informatics Market - India
  - 9.5.6.1. India: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.5.6.2. India: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.5.6.3. India: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.5.6.4. India: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.5.7. Drug Discovery Informatics Market - Malaysia
  - 9.5.7.1. Malaysia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.5.7.2. Malaysia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.5.7.3. Malaysia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.5.7.4. Malaysia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.5.8. Drug Discovery Informatics Market - Japan
  - 9.5.8.1. Japan: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.5.8.2. Japan: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.5.8.3. Japan: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.5.8.4. Japan: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.5.9. Drug Discovery Informatics Market - Indonesia
  - 9.5.9.1. Indonesia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.5.9.2. Indonesia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.5.9.3. Indonesia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.5.9.4. Indonesia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.5.10. Drug Discovery Informatics Market - South Korea
  - 9.5.10.1. South Korea: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.5.10.2. South Korea: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.5.10.3. South Korea: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.5.10.4. South Korea: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.5.11. Drug Discovery Informatics Market - Australia
  - 9.5.11.1. Australia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.5.11.2. Australia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.5.11.3. Australia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.5.11.4. Australia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.5.12. Drug Discovery Informatics Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.5.12.2. Rest of Asia Pacific: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.5.12.3. Rest of Asia Pacific: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.5.12.4. Rest of Asia Pacific: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
9.6. Drug Discovery Informatics Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
- 9.6.2. Middle East & Africa: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
- 9.6.3. Middle East & Africa: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
- 9.6.4. Middle East & Africa: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.6.5. Drug Discovery Informatics Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.6.5.2. Saudi Arabia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.6.5.3. Saudi Arabia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.6.5.4. Saudi Arabia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.6.6. Drug Discovery Informatics Market - UAE
  - 9.6.6.1. UAE: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.6.6.2. UAE: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.6.6.3. UAE: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.6.6.4. UAE: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.6.7. Drug Discovery Informatics Market - Israel
  - 9.6.7.1. Israel: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.6.7.2. Israel: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.6.7.3. Israel: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.6.7.4. Israel: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.6.8. Drug Discovery Informatics Market - South Africa
  - 9.6.8.1. South Africa: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.6.8.2. South Africa: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.6.8.3. South Africa: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.6.8.4. South Africa: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.6.9. Drug Discovery Informatics Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.6.9.2. Rest of Middle East & Africa: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.6.9.3. Rest of Middle East & Africa: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.6.9.4. Rest of Middle East & Africa: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
9.7. Drug Discovery Informatics Market - Latin America
- 9.7.1. Latin America: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
- 9.7.2. Latin America: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
- 9.7.3. Latin America: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
- 9.7.4. Latin America: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.7.5. Drug Discovery Informatics Market - Mexico
  - 9.7.5.1. Mexico: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.7.5.2. Mexico: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.7.5.3. Mexico: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.7.5.4. Mexico: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.7.6. Drug Discovery Informatics Market - Brazil
  - 9.7.6.1. Brazil: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.7.6.2. Brazil: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.7.6.3. Brazil: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.7.6.4. Brazil: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.7.7. Drug Discovery Informatics Market - Argentina
  - 9.7.7.1. Argentina: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.7.7.2. Argentina: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.7.7.3. Argentina: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.7.7.4. Argentina: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.7.8. Drug Discovery Informatics Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.7.8.2. Rest of Latin America: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.7.8.3. Rest of Latin America: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.7.8.4. Rest of Latin America: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Accenture
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Agilent Technologies, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Boehringer Ingelheim International GmbH
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Certara
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Charles River Laboratories
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Chemaxon Ltd.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Collaborative Drug Discovery Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Eurofins DiscoverX Products
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Illumina, Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Infosys Limited
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Jubilant Biosys Ltd.
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Oracle
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. QIAGEN
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Sapio Sciences
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
11.15. Selvita
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development